Articles
Boston based hair growth company Follica has announced positive data from its ongoing safety and optimization study and is prepared to move into a pivotal FDA study later this year. Upon checking my email this morning I found a message from a top level executive at Follica pointing me to a press release sent out…
A new company with an interesting pipeline aimed at hair growth technology, Applied Biology, has recently surfaced on the internet. Background Applied Biology is a biotechnology company based in Irvine, California and led by dermatologist Dr. Andy Goren. The company’s About page gives a good description of Applied Biology’s focus: “Applied Biology is a biotechnology…
Today, on June 6th 2019, Aclaris made its annual presentation at the Jeffries Global Healthcare Conference in New York City. Eyebrow Growth To Start Aclaris CEO Dr. Neal Walker made the presentation on behalf of his company and shared some impressive eyelash growth results. The slide is shared below and depicts the before photos on the…
After initiating a rousing new trial for female hair loss last year, Histogen has been back on many people’s radar again. A video of Histogen’s recent presentation in New York City has been uploaded online and it contains some interesting items from the company. New CEO One news item coming from Histogen earlier this year…
Back in August 2017, UCLA researchers made headlines by discovering a new way to activate hair follicle stem cells. This was done through a metabolite called lactate. William Lowry and Heather Christofk of UCLA’s Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research were responsible for the lactate discovery. Lowry and Christofk…
CEO of Follicum, Jan Alenfall, recently presented his company at the BioStock meeting which took place on April 29, 2019 in Stockholm, Sweden. The presentation details Follicum’s successes and plans for its diabetes and hair growth programs. Follicum’s hair growth program is composed of its peptide drug called FOL-005.The section discussing the hair growth program…
Yesterday, Replicel released a May 2019 Update which mentioned a new study using its dermal injector device to treat hair loss. The end of the press release states: “Over the next 18 months you should expect to see: new clinical data from a study completed showing the value of the dermal injector in treating hair…
It appears that the Shiseido trial results for Replicel’s RCH-01 will finally be revealed sometime around July 2019. In my post on WCHR 2019 Highlights a commenter named Neez shared this message: “Someone working on the rch-01 trial send this mail to a guy asking about the phase II results: Dear *****, The results will…
Once again, Follicle Thought is pleased to share some remarkable results from RiverTown Therapeutics’ RT1640. Precision Results The photos below include an alternate angle of a 6 month result which was previously shared in the RiverTown Game Changer article. This time an arrow has been added to the photo to indicate a birthmark for proper…
On April 24th-27th 2019 the 11th World Congress for Hair Research took place in Sitges, Barcelona. Usually, major announcements regarding the release of new treatments are not made at such conferences, however, worthwhile scientific information is typically shared. Importantly, companies who attend the WCHR are sometimes able to create business development opportunities. Below are some…